title: Conditional deletion of cytochrome p450 reductase in osteoprogenitor cells affects long bone and skull development in mice recapitulating antley-bixler syndrome: role of a redox enzyme in development.
abstract: NADPH-cytochrome P450 oxidoreductase (POR) is the primary electron donor for cytochromes P450, dehydrocholesterol reductase, heme oxygenase, and squalene monooxygenase. Human patients with specific mutations in POR exhibit severe developmental malformations including disordered steroidogenesis, sexual ambiguities and various bone defects, similar to those seen in patients with Antley-Bixler syndrome (ABS). To probe the role of POR during bone development, we generated a conditional knockout mouse (CKO) by cross breeding Por (lox/lox) and Dermo1 Cre mice. CKO mice were smaller than their littermate controls and exhibited significant craniofacial and long bone abnormalities. Differential staining of the CKO mice skull bases shows premature fusion of the sphenooccipital and basioccipital-exoccipital synchondroses. Class III malocclusion was noted in adult knockout mice with an unusual overgrowth of the lower incisors. Shorter long bones were observed along with a reduction in the bone volume fraction, measured by microCT, in the Por-deleted mice compared to age- and sex-matched littermate controls. Concerted up- or down-regulation of proteins in the FGF signaling pathway observed by immunohistochemistry in the tibia samples of CKO mice compared to wild type controls shows a decrease in the FGF signaling pathway. To our knowledge, this is the first report of a mouse model that recapitulates both skull and long bone defects upon Por deletion, offering an approach to study the sequelae of POR mutations. This unique model demonstrates that P450 metabolism in bone itself is potentially important for proper bone development, and that an apparent link exists between the POR and FGF signaling pathways, begging the question of how an oxidation-reduction flavoprotein affects developmental and cellular signaling processes.
authors.affiliation: Department of Biochemistry, University of Texas Health Science Center, San Antonio, Texas, United States of America.
authors.forename: Satya P
authors.initials: SP
authors.lastname: Panda
authors.forename: Anyonya R
authors.initials: AR
authors.lastname: Guntur
authors.forename: Srikanth R
authors.initials: SR
authors.lastname: Polusani
authors.forename: Roberto J
authors.initials: RJ
authors.lastname: Fajardo
authors.forename: Peter T
authors.initials: PT
authors.lastname: Gakunga
authors.forename: Linda J
authors.initials: LJ
authors.lastname: Roman
authors.forename: Bettie Sue
authors.initials: BS
authors.lastname: Masters
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D000818:Animals; D054882:Antley-Bixler Syndrome Phenotype / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D001846:Bone Development / Q000235:genetics* / Q000502:physiology*; D015536:Down-Regulation / Q000235:genetics; D005260:Female; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000378:metabolism; D008297:Male; D059630:Mesenchymal Stem Cells / Q000378:metabolism / Q000502:physiology; D051379:Mice; D018345:Mice, Knockout; D009154:Mutation / Q000235:genetics; D009251:NADPH-Ferrihemoprotein Reductase / Q000235:genetics* / Q000378:metabolism; D010084:Oxidation-Reduction; D017384:Sequence Deletion / Q000235:genetics*; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D012886:Skull / Q000254:growth & development / Q000378:metabolism; D013234:Stem Cells / Q000378:metabolism* / Q000502:physiology; D013977:Tibia / Q000254:growth & development / Q000378:metabolism; D015854:Up-Regulation / Q000235:genetics
chemical_list: D005346:Fibroblast Growth Factors; D009251:NADPH-Ferrihemoprotein Reductase